FDA OKs Once-Nightly Lumryz for Children With Narcolepsy 🔗 Access full article via Medscape NeurologyLumryz is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in children as young as 7 years with narcolepsy. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
